Year None2022202120202019201820172016201520142012 Aug 11, 2022 Graybug Vision Reports Financial Results for the Three and Six Months Ended June 30, 2022, and Recent Corporate Developments Jul 06, 2022 Graybug to Present at the 2022 OIS Retina Innovation Summit Jun 28, 2022 Graybug Announces Review of Strategic Alternatives May 19, 2022 Graybug to Present Clinical Development Plan Update for GB-102 at the 2022 Clinical Trials at the Summit Meeting May 10, 2022 Graybug Vision Reports First Quarter 2022 Financial Results and Recent Corporate Developments Apr 27, 2022 Graybug to Present Preclinical Data for GB-401 in Primary Open-Angle Glaucoma at the 2022 ARVO Annual Meeting Apr 18, 2022 Graybug to Present at the 2022 ASCRS Annual Meeting Apr 13, 2022 Graybug Vision Appoints Dirk Sauer to Board of Directors Mar 30, 2022 Graybug Announces Pipeline Expansion, Current Cash Expected to Deliver Three Clinical Readouts in 2023 Mar 21, 2022 Graybug Vision to Host Virtual R&D Day on March 30, 2022 Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 13
Aug 11, 2022 Graybug Vision Reports Financial Results for the Three and Six Months Ended June 30, 2022, and Recent Corporate Developments
May 19, 2022 Graybug to Present Clinical Development Plan Update for GB-102 at the 2022 Clinical Trials at the Summit Meeting
May 10, 2022 Graybug Vision Reports First Quarter 2022 Financial Results and Recent Corporate Developments
Apr 27, 2022 Graybug to Present Preclinical Data for GB-401 in Primary Open-Angle Glaucoma at the 2022 ARVO Annual Meeting
Mar 30, 2022 Graybug Announces Pipeline Expansion, Current Cash Expected to Deliver Three Clinical Readouts in 2023
